Non‐cardiogenic pulmonary oedema induced by salazosulfapyridine

Takashi Saito,Y. Mori,Mitsuo Yoshida,T. Maeta,F. Koui,M. Harada

DOI: https://doi.org/10.1111/j.1440-1843.2005.00734.x

2005-09-01

Abstract:Abstract:  A 25‐year‐old woman received oral salazosulfapyridine, 4 g/day, for treatment of ulcerative colitis. At 10 days later, she presented with fever and respiratory symptoms. Based on physical, laboratory and radiological findings, bacterial pneumonia and non‐cardiogenic pulmonary oedema was suspected. Salazosulfapyridine was immediately halted and antibiotic therapy started. Two days later, her symptoms and abnormal findings had improved rapidly. Bacteriological studies were negative. Salazosulfapyridine‐induced non‐cardiogenic pulmonary oedema was diagnosed. Non‐cardiogenic pulmonary oedema should be considered as one of several salazosulfapyridine‐ induced pulmonary diseases in patients who are receiving salazosulfapyridine and who develop respiratory symptoms and an abnormal CXR.